Brewin Dolphin Wealth Management’s Pfizer PFE Stock Holding History

Brewin Dolphin Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1.85M	Sell	35,377 -1,200	-3%	-$61.2K	0.2%	52
2022 Q1	$1.89M	Buy	36,577 +150	+0.4%	+$7.78K	0.21%	56
2021 Q4	$2.15M	Sell	36,427 -3,860	-10%	-$191K	0.23%	54
2021 Q3	$1.73M	Hold	40,287	–	–	0.2%	60
2021 Q2	$1.58M	Sell	40,287 -13,790	-26%	-$536K	0.19%	63
2021 Q1	$1.96M	Buy	54,077 +225	+0.4%	+$7.99K	0.3%	50
2020 Q4	$1.98M	Sell	53,852 -3,172	-6%	-$116K	0.33%	46
2020 Q3	$1.99M	Buy	57,024 +449	+0.8%	+$15.7K	0.37%	41
2020 Q2	$1.76M	Buy	56,575 +1,118	+2%	+$38K	0.38%	40
2020 Q1	$1.72M	Buy	55,457 +316	+0.6%	+$10.8K	0.93%	25
2019 Q4	$2.05M	Sell	55,141 -1,265	-2%	-$45.1K	0.95%	26
2019 Q3	$1.92M	Sell	56,406 -263	-0.5%	-$9.56K	0.98%	25
2019 Q2	$2.33M	Buy	56,669 +2,258	+4%	+$89.7K	1.21%	24
2019 Q1	$2.19M	Sell	54,411 -874	-2%	-$35K	1.19%	24
2018 Q4	$2.29M	Sell	55,285 -106	-0.2%	-$4.4K	1.39%	23
2018 Q3	$2.32M	Hold	55,391	–	–	1.25%	23
2018 Q2	$1.91M	Buy	55,391 +4,543	+9%	+$155K	1.13%	23
2018 Q1	$1.71M	Buy	50,848 +3,689	+8%	+$127K	1.06%	26
2017 Q4	$1.62M	Buy	47,159 +5,228	+12%	+$178K	1.03%	28
2017 Q3	$1.42M	Buy	+41,931	New	+$1.35M	0.99%	29

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Brewin Dolphin Wealth Management's PFE Position: Q2 2022 in Review

Brewin Dolphin Wealth Management reduced its Pfizer (PFE) stake by 3.3% in Q2 2022, selling an estimated $61.2K and leaving 35,377 shares worth $1.85M. The position accounts for 0.2% of the portfolio, ranked #52.

Brewin Dolphin Wealth Management first reported a position in PFE in Q3 2017 and has held it in 20 quarters since. The position peaked at $2.33M in Q2 2019. 3,157 funds tracked by Wall St. Rank hold PFE as of Q2 2022.

Brewin Dolphin Wealth Management held 35,377 shares of Pfizer worth $1.85M as of Q2 2022.
Brewin Dolphin Wealth Management sold 1,200 Pfizer shares in Q2 2022, an estimated $61.2K.
Pfizer made up 0.2% of Brewin Dolphin Wealth Management's portfolio in Q2 2022, its #52 holding.
Brewin Dolphin Wealth Management first reported a position in Pfizer in Q3 2017 and has held it in 20 quarters since.
Brewin Dolphin Wealth Management's Pfizer position peaked at $2.33M in Q2 2019.
3,157 funds tracked by Wall St. Rank held Pfizer as of Q2 2022.

Based on Brewin Dolphin Wealth Management's 13F filing for Q2 2022, filed 14 Nov 2022.